查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813814

全球小分子創新 CDMO 市場：市場規模、佔有率和趨勢分析（按產品、階段類型、治療領域、客戶類型和地區）、按細分市場預測（2025-2033 年）

Small Molecule Innovator CDMO Market Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type (Clinical, Commercial), By Therapeutic Area, By Customer Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

小分子創新CDMO市場摘要

預計 2024 年全球小分子創新 CDMO 市場價值將達到 413.9 億美元，到 2033 年將達到 693.8 億美元，2025 年至 2033 年的複合年成長率為 6.07%。

新興市場的成長是由越來越多的製藥公司將藥物開發和製造外包所推動的，特別是在小分子領域。

隨著藥物管道變得越來越複雜以及監管審查的加強，製藥公司越來越依賴 CDMO 來提供專業服務，例如原料藥合成、製劑開發和臨床規模生產。製藥公司越來越依賴外包，因為他們尋求簡化營運、減少內部製造負擔並縮短藥物開發時間，這推動了市場的發展。創新者，尤其是基礎設施有限的新興生物技術公司，擴大轉向 CDMO 尋求從早期開發到商業製造的專業服務。監管合規的複雜性、對高活性原料藥的先進遏制設施的需求以及維持內部能力的高成本強化了這一趨勢。針對癌症、感染疾病和罕見疾病的臨床試驗和新分子實體 (NME) 的興起正在推動對在 cGMP 條件下提供高品質原料藥製造、分析測試和製劑開發專業知識的 CDMO 的需求。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 小分子創新 CDMO 市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 小分子創新者 CDMO 市場動態
  • 技術格局
  • 定價模式分析
  • 小分子創新者 CDMO 市場：分析工具

第4章 小分子創新 CDMO 市場：依產品的估計與趨勢分析

  • 細分儀表板
  • 全球小分子創新 CDMO 市場：按產品分類的變化分析
  • 全球小分子創新 CDMO 市場規模與趨勢分析（按產品）（2021-2033 年）
  • 小分子API
  • 小分子藥物
    • 口服固態劑型
    • 半固態
    • 液體劑型
    • 其他

第5章 小分子創新 CDMO 市場：依階段類型估計與趨勢分析

  • 細分儀表板
  • 全球小分子創新 CDMO 市場：以階段類型變化分析
  • 全球小分子創新 CDMO 市場規模與趨勢分析（按階段類型）（2021-2033 年）
  • 臨床前
  • 臨床
    • 第一階段
    • 第二階段
    • 第三階段
  • 上市

6. 小分子創新 CDMO 市場：按客戶類型進行的估計和趨勢分析

  • 細分儀表板
  • 全球小分子創新 CDMO 市場：依客戶類型進行趨勢分析
  • 全球小分子創新 CDMO 市場規模與趨勢分析（按客戶類型）（2021-2033 年）
  • 製藥
    • 小型企業
    • 中型公司
    • 主要企業
  • 生物技術

7. 小分子創新 CDMO 市場：依治療領域的估計與趨勢分析

  • 細分儀表板
  • 全球小分子創新 CDMO 市場：依治療領域變化分析
  • 全球小分子創新 CDMO 市場規模及趨勢分析（依治療領域）（2021-2033 年）
  • 心血管疾病
  • 腫瘤學
  • 呼吸系統疾病
  • 神經病學
  • 代謝紊亂
  • 感染疾病
  • 其他

8. 小分子創新 CDMO 市場：區域估計和趨勢分析（按產品、藥物類型和應用）

  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 小分子創新者 CDMO 市佔率分析（2024 年）
  • 公司簡介
    • Piramal Pharma Solutions
    • CordenPharma International
    • Wuxi AppTec
    • Cambrex Corporation
    • Recipharm AB
    • Thermo Fisher Scientific, Inc.
    • Lonza
    • Catalent Inc.
    • Siegfried Holding AG
    • Boehringer Ingelheim
    • Labcorp
Product Code: GVR-4-68039-908-0

Small Molecule Innovator CDMO Market Summary

The global small molecule innovator CDMO market size was estimated at USD 41.39 billion in 2024 and is projected to reach USD 69.38 billion by 2033, growing at a CAGR of 6.07% from 2025 to 2033. The growth of the market is due to the increasing outsourcing of drug development and manufacturing by pharmaceutical innovators, particularly in the small molecule space.

As drug pipelines become more complex and regulatory scrutiny tightens, pharmaceutical companies are relying more on CDMOs to provide specialized services such as API synthesis, formulation development, and clinical-scale production. The market is driven by a growing reliance on outsourcing among pharmaceutical companies aiming to streamline operations, reduce internal manufacturing burdens, and accelerate drug development timelines. Innovator companies, especially emerging biotechs with limited infrastructure, increasingly turn to CDMOs for specialized services ranging from early-phase development to commercial manufacturing. This trend is reinforced by the complexity of regulatory compliance, the need for advanced containment facilities for potent APIs, and the high costs associated with maintaining in-house capabilities. The rise in clinical trials and new molecular entities (NMEs) targeting oncology, infectious diseases, and rare disorders is pushing demand for CDMOs that offer high-quality API production, analytical testing, and formulation development expertise under cGMP conditions.

Global Small Molecule Innovator CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule innovator CDMO market report based on product, stage type, customer type, therapeutic area, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecule API
  • Small Molecule Drug Product
    • Oral Solid Dose
    • Semi-Solid Dose
    • Liquid Dose
    • Others
  • Stage Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Preclinical
  • Clinical
    • Phase I
    • Small
    • Medium
    • Large
    • Phase II
    • Small
    • Medium
    • Large
    • Phase III
    • Small
    • Medium
    • Large
  • Commercial
  • Customer Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical
    • Small
    • Medium
    • Large
  • Biotechnology
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Diseases
  • Oncology
  • Respiratory Disorders
  • Neurology
  • Metabolic Disorders
  • Infectious Diseases
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Small Molecule Innovator CDMO Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Small Molecule Innovator CDMO Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Small Molecule Innovator CDMO Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Small Molecule Innovator CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Small Molecule Innovator CDMO Market Product Movement Analysis
  • 4.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Small Molecule API
    • 4.4.1. Small Molecule API Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Small Molecule Drug Product
    • 4.5.1. Small Molecule Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.2. Oral Solid Dose
      • 4.5.2.1. Oral Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.3. Semi-Solid Dose
      • 4.5.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.4. Liquid Dose
      • 4.5.4.1. Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD million)

Chapter 5. Small Molecule Innovator CDMO Market: Stage Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Small Molecule Innovator CDMO Market Stage Type Movement Analysis
  • 5.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Stage Type, 2021 to 2033 (USD Million)
  • 5.4. Preclinical
    • 5.4.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Clinical
    • 5.5.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Phase I
      • 5.5.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.2. Small
        • 5.5.2.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.3. Medium
        • 5.5.2.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.2.4. Large
        • 5.5.2.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 5.5.3. Phase II
      • 5.5.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.2. Small
        • 5.5.3.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.3. Medium
        • 5.5.3.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.3.4. Large
        • 5.5.3.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 5.5.4. Phase III
      • 5.5.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.2. Small
        • 5.5.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.3. Medium
        • 5.5.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
      • 5.5.4.4. Large
        • 5.5.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 5.6. Commercial
    • 5.6.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule Innovator CDMO Market: Customer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Small Molecule Innovator CDMO Market Customer Type Movement Analysis
  • 6.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Customer Type, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical
    • 6.4.1. Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Small
      • 6.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Medium
      • 6.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Large
      • 6.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biotechnology
    • 6.5.1. Biotechnology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule Innovator CDMO Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Small Molecule Innovator CDMO Market Therapeutic Area Movement Analysis
  • 7.3. Global Small Molecule Innovator CDMO Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 7.4. Cardiovascular diseases
    • 7.4.1. Cardiovascular diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Respiratory disorders
    • 7.6.1. Respiratory disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Metabolic Disorders
    • 7.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Infectious Diseases
    • 7.9.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Others
    • 7.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Small Molecule Innovator CDMO Market: Regional Estimates & Trend Analysis by Product, Drug Type, Application

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Small Molecule Innovator CDMO Market Share Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Piramal Pharma Solutions
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. CordenPharma International
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Wuxi AppTec
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Cambrex Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Recipharm AB
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Thermo Fisher Scientific, Inc.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Lonza
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Catalent Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Siegfried Holding AG
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Boehringer Ingelheim
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Labcorp
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 5 North America Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 6 North America Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 9 U.S. Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 10 U.S. Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 11 Canada Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 13 Canada Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 14 Canada Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 15 Mexico Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 16 Mexico Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 19 Europe Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 20 Europe Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 22 Europe Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 23 Europe Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 24 Germany Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 26 Germany Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 27 Germany Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 28 UK Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 29 UK Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 30 UK Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 31 UK Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 32 France Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 33 France Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 34 France Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 35 France Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 36 Italy Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 37 Italy Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 38 Italy Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 39 Italy Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 40 Spain Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 41 Spain Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 42 Spain Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 43 Spain Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 44 Denmark Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 45 Denmark Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 46 Denmark Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 47 Denmark Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 48 Sweden Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 49 Sweden Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 50 Sweden Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 51 Sweden Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 52 Norway Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 53 Norway Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 54 Norway Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 55 Norway Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 61 China Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 62 China Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 63 China Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 64 China Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 65 Japan Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 66 Japan Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 67 Japan Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 68 Japan Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 69 India Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 70 India Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 71 India Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 72 India Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 73 South Korea Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 74 South Korea Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 75 South Korea Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 76 South Korea Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 77 Australia Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 78 Australia Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 79 Australia Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 80 Australia Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 81 Thailand Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 82 Thailand Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 83 Thailand Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 85 Latin America Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 86 Latin America Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 87 Latin America Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 88 Latin America Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 89 Latin America Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 90 Brazil Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 91 Brazil Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 92 Brazil Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 93 Brazil Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 94 Argentina Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 95 Argentina Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 96 Argentina Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 97 Argentina Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 98 MEA Small Molecule Innovator CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 99 MEA Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 100 MEA Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 101 MEA Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 102 MEA Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 103 South Africa Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 104 South Africa Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 105 South Africa Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 106 South Africa Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 111 UAE Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 112 UAE Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 113 UAE Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 114 UAE Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 115 Kuwait Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Small Molecule Innovator CDMO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Small Molecule Innovator CDMO market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Small Molecule Innovator CDMO market Product outlook: Segment dashboard
  • Fig. 22 Small Molecule Innovator CDMO market, by Product segment: Market share, 2024 & 2033
  • Fig. 23 Small Molecule API market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Small Molecule Drug Product market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Oral Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Semi-Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Liquid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Small Molecule Innovator CDMO market Stage Type outlook: Segment dashboard
  • Fig. 30 Small Molecule Innovator CDMO market, by Stage Type segment: Market share, 2024 & 2033
  • Fig. 31 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Small phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Medium phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Large phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Phase II market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 38 Small phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Medium phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Large phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Small phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Medium phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Large phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Small Molecule Innovator CDMO market Customer Type outlook: Segment dashboard
  • Fig. 46 Small Molecule Innovator CDMO market, by Customer Type segment: Market share, 2024 & 2033
  • Fig. 47 Pharmaceutical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Small pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Medium pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Large pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Biotechnology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Small Molecule Innovator CDMO market Therapeutic Area outlook: Segment dashboard
  • Fig. 53 Small Molecule Innovator CDMO market, by Therapeutic Area segment: Market share, 2024 & 2033
  • Fig. 54 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Respiratory disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Neurology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Metabolic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Regional market: Key takeaways
  • Fig. 62 Regional marketplace: Key takeaways
  • Fig. 63 North America Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 U S Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Canada Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Mexico Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Europe Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 UK Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Germany Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 France Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Italy Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Spain Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Denmark Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Norway Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Sweden Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Asia Pacific Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Japan Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 China Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 India Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Australia Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 South Korea Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Thailand Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Latin America Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Brazil Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Argentina Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 MEA Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 South Africa Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Saudi Arabia Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Kuwait Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 UAE Small Molecule Innovator CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Market participant categorization
  • Fig. 115 Heat map analysis